TNFRSF11B and cancer: Given the considerable experimental and preclinical data implicating RANK signaling in mammary tumorigenesis, there has been increasing interest in the quantification of either circulating sRANKL, OPG, or even the sRANKL/OPG ratio as potential biomarkers of cancer risk.